Quetiapine is an atypical antipsychotic medication that is available as a generic drug and marketed under brand names such as Seroquel. It belongs to the mental health therapeutic class and is supplied in pill form in the following strengths: 25 mg, 50 mg, 100 mg, 200 mg, and 300 mg. In Hong Kong, quetiapine is a prescription-only medication regulated by the Department of Health.
Quetiapine exerts its therapeutic effects through multiple receptor actions:
The drug is well-absorbed after oral administration, reaching peak plasma concentrations in about 1.5 hours. It undergoes extensive hepatic metabolism, primarily via the CYP3A4 enzyme, and its active metabolite (norquetiapine) also contributes to clinical effects. The overall duration of action supports once-daily or twice-daily dosing depending on the condition being treated.
Quetiapine is approved by regulatory agencies for the following indications in Hong Kong:
These approvals are based on robust clinical trial data demonstrating efficacy in reducing psychotic symptoms, stabilizing mood, and improving depressive outcomes.
Quetiapine has been investigated for several off-label applications:
Off-label use requires medical supervision and individualized risk assessment.
Absolute contraindications
Relative contraindications
Patients with renal or hepatic impairment may require dose adjustments and close monitoring.
Special populations
Administration tips
Missed dose - take the missed tablet as soon as remembered unless it is close to the next scheduled dose; do not double-dose.
Overdose - symptoms may include extreme drowsiness, hypotension, and cardiac arrhythmias. Seek emergency medical care; supportive measures and cardiac monitoring are the mainstays of treatment.
Discontinuation - abrupt cessation can lead to rebound insomnia or agitation. A gradual taper, guided by a healthcare professional, is advised.
This article provides educational information about quetiapine and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Quetiapine is sometimes prescribed off-label at low doses for insomnia, but it carries risks such as weight gain and metabolic effects. Use only under medical supervision.
Severe dizziness may indicate hypotension or orthostatic changes; contact a healthcare professional promptly to assess the need for dose adjustment.
There are no strict food restrictions, but high-fat meals can slightly delay absorption. Alcohol should be avoided because it amplifies sedation.
Monitor fasting glucose regularly; an unexplained rise may signal drug-induced hyperglycaemia, warranting discussion with your clinician.
Both contain the same active ingredient and are bioequivalent; however, inactive excipients may differ, which can affect tolerability in sensitive individuals.
Patients with cardiac conditions should have a baseline ECG and be monitored for QTc prolongation; dose adjustments may be necessary.
Certain supplements, such as St. John’s Wort (a CYP3A4 inducer), can lower quetiapine levels, potentially reducing efficacy. Always disclose supplement use to your provider.
Store at room temperature (20-25 °C), away from moisture, heat, and direct sunlight, in the original container with the label intact.
Mood benefits may begin within 1-2 weeks, but full therapeutic effect often requires several weeks of consistent dosing.
Carry the medication in its original packaging with a copy of the prescription, keep it in your carry-on bag, and be aware of any import restrictions at your destination.